http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-2906239-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e987ddd7d0967e4278a229b67adf8809
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-30
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-30
filingDate 1979-02-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8ea82583370275d77e86d46fd23f51dc
publicationDate 1980-08-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber DE-2906239-A1
titleOfInvention RIGHT-ROTATING (+) - ENANTIOMERES AND LEFT-ROTATING (-) - ENANTIOMERES OF BETA -DIMETHYL-AMINO-AETHYL- (PHENYL-METHYL-2-PYRIDYL) -CARBINOLAETHERS
abstract New cpds. are (+) - and (-)-enantiomers of 2-dimethylamino-ethyl phenyl-methyl-(2-pyridyl)-carbinol ether (doxylamine) (I), and their salts with organic carboxylic acids (esp dicarboxylic acids). In the guinea-pig isolated ileum prepn, (+)-(I) has more antihistaminic action at a lower concs than (-) - (I). (+)- (I) prolongs hexobarbital sleeping time in guinea pigs, while (-)-(I) greatly reduces this (+)-(i) is useful as an anthihistamine and/or as a sedative and hypnotic agent, while (-)-(I) is useful as an anthihistaminc for daytime use.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103467365-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107098851-A
priorityDate 1979-02-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5818
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451878892
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419504599
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11224
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23664950
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450177930
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2564
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419557670
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6211
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4761
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID439655
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426517444
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452756786
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419502345
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3667129
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID408499459
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID69312092
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID408499458
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393783
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419546610
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21585056
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21583978
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559261
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3608
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419570570
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID10141
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3283
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11391247
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419491034
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3162
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID10141
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID444305
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457192901
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421935945
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419491874

Total number of triples: 50.